Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
NovoRapid (insulin aspart) and Levemir (insulin detemir) - Important Safety Information from Novo Nordisk as approved from the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
12/12/2006
Problem Or Issue:
NovoRapid (insulin aspart) and Levemir (insulin detemir) - Please find attached Important Safety Communication regarding NovoRapid (insulin detemir) and Levemir (insulin detemir) Medication Errors
« Back
Date Printed: 28/03/2024